Tyrosine kinases in AML: where do they fit in?

Publisher： Elsevier

ISSN： 0145-2126

Source： Leukemia Research, Vol.28, Iss.3, 2004-03, pp. : 217-218

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Tyrosine Kinases and Inflammatory Signalling

Current Molecular Medicine, Vol. 9, Iss. 1, 2009-02 ,pp. : 69-85

Bentham Science Publishers

Access to resources Recommend Favorite

Receptor tyrosine kinases as targets for anticancer drugs

By Zwick E. Bange J. Ullrich A.

Trends in Molecular Medicine, Vol. 8, Iss. 1, 2002-01 ,pp. : 17-23

Elsevier

Access to resources Recommend Favorite

Where does radioimmunotherapy fit in the management of breast cancer?

By Doddamane Indu Butler Reni Jhaveri Ami Chung Gina G Cheng David

Immunotherapy, Vol. 5, Iss. 8, 2013-08 ,pp. : 895-904

Future Medicine

Access to resources Recommend Favorite

EGF and PDGF Receptor Tyrosine Kinases as Therapeutic Targets for Chronic Lung Diseases

Current Molecular Medicine, Vol. 6, Iss. 4, 2006-06 ,pp. : 409-421

Bentham Science Publishers

Access to resources Recommend Favorite

Do phosphoinositide 3-kinases direct lymphocyte navigation?

By Ward S.G.

Trends in Immunology, Vol. 25, Iss. 2, 2004-02 ,pp. : 67-74

Elsevier

Access to resources Recommend Favorite